Elevating NAD+ while inhibiting its methylation loss through NNMT inhibition may enhance mitochondrial biogenesis and oxidative phosphorylation efficiency
The NNMT-blocking mechanism of 5-amino-1MQ has been shown to increase levels of the cofactor NAD+, whose replenishment in organisms promotes muscular, cognitive, and immune function, as well as increased lifespan [4, 5]
It enhances GH output and lipolysis, making it a strong partner in fat loss stacks
The peptide also increases NAD+ levels, which activate the SIRT1 gene
This enzymatic overactivity is strongly associated with obesity, insulin resistance, and metabolic syndrome
It also lowers triglycerides and cholesterol levels, which can enhance heart health